American Society of Hematology

Action Alerts

From time to time ASH will call on its members to reach out to Congress and state legislatures on issues of importance to hematologists and their patients. Below is a list of current issues of importance.

Federal Campaigns

Contact Congress in Support of Sustained and Predictable Funding for NIH
ASH has strongly urged Congress to provide increased funding for NIH. Flat or reduced funding for NIH would delay progress and prevent valuable research from turning into tomorrow's cures. As annual spending legislation makes its way through Congress, it's important that your elected officials hear from you about why biomedical research is important to you and the patients that you treat.

Urge your Representative to Support the Cancer Drug Parity Act
Legislation has been introduced in the U.S. House of Representatives that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens. Your Representative needs to cosponsor these bills in order for them to be considered by the full Congress.

Contact Your Senators in Support of Sickle Cell Disease Legislation
Legislation to help improve outcomes for patients suffering from sickle cell disease (SCD) has successfully passed out of the House of Representatives and companion legislation has been introduced in the Senate. The Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 aims to improve understanding of health care system utilization patterns of people with SCD and establish cost-effective practices to improve and extend the lives of patients.

State-Level Campaigns

Contact Your Michigan House Member to Support HB 5367
Legislation has been introduced in the Michigan House of Representatives that would ensure that patients have access and insurance coverage for all anti-cancer regimens regardless of the form that they take.

Contact Your North Carolina State Senator in Support of H. 206
The Cancer Treatment Fairness Act (H.206) would require any health plan that provides coverage for cancer chemotherapy treatment to provide coverage for orally administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port-administered, or injected anticancer medications. It is important you reach out to ask for your North Carolina state Senator's support.

back to top